Evaluation of iStent® Inject W in mild to moderate primary open-angle glaucoma – Indian data on pseudophakic eyes
Year: 2026
Type: article
Study design: Clinical Trial
Abstract: PURPOSE: This study aimed to evaluate the safety and efficacy of standalone bilateral iStent® Inject W implantation in pseudophakic patients with mild to moderate primary open-angle glaucoma (POAG) over 18 months. DESIGN: Prospective, longitudinal study. METHODS: Twenty-eight pseudophakic eyes with mild to moderate POAG were implanted with iStent® Inject W. Outcome measures included intraocular pressure (IOP) and change in the number of antiglaucoma medications. RESULTS: The mean IOP declined from 21.14 ± 2.18 mmHg preoperatively to 15.14 ± 1.51 mmHg at 18 months postoperatively ( P < 0.0001), while the average number of antiglaucoma medications was reduced from 2.07 ± 0.73 to 1.18 ± 0.83 over the same period ( P < 0.05). CONCLUSION: Standalone iStent® Inject W implantation in pseudophakic patients with mild to moderate POAG results in a sustained reduction in IOP and the number of antiglaucoma medications at 18 months postoperatively.
Source: Indian Journal of Ophthalmology
Authors: Chandrima Paul, Anujeet Paul, Nusrat Faruque
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7214799164